Bolsa Ferruz et al., 2017 - Google Patents
New research in ionizing radiation and nanoparticles: the ARGENT projectBolsa Ferruz et al., 2017
- Document ID
- 8447132715061471351
- Author
- Bolsa Ferruz M
- Ivošev V
- Haume K
- Ellis-Gibbings L
- Traore A
- Thakare V
- Rosa S
- de Vera P
- Tran V
- Mika A
- Boscolo D
- Grellet S
- Verkhovtsev A
- Huber B
- Butterworth K
- Prise K
- Currell F
- Mason N
- Golding J
- Scifoni E
- García G
- Boschetti F
- Lux F
- Tillement O
- Louis C
- Stokbro K
- Solov’yov A
- Lacombe S
- Publication year
- Publication venue
- Nanoscale Insights into Ion-Beam Cancer Therapy
External Links
Snippet
This chapter gives an overview of “ARGENT”(“Advanced Radiotherapy, Generated by Exploiting Nanoprocesses and Technologies”), an ongoing international Initial Training Network project, supported by the European Commission. The project, bringing together …
- 239000002105 nanoparticle 0 title abstract description 259
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1077—Beam delivery systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schuemann et al. | Roadmap for metal nanoparticles in radiation therapy: Current status, translational challenges, and future directions | |
| Kuncic et al. | Nanoparticle radio-enhancement: principles, progress and application to cancer treatment | |
| Haume et al. | Gold nanoparticles for cancer radiotherapy: a review | |
| Xia et al. | Au–hemoglobin loaded platelet alleviating tumor hypoxia and enhancing the radiotherapy effect with low-dose X-ray | |
| Lux et al. | AGuIX® from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine | |
| Shen et al. | Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors | |
| Qi et al. | Tumor-specific activatable nanocarriers with gas-generation and signal amplification capabilities for tumor theranostics | |
| Li et al. | Au@ MnS@ ZnS core/shell/shell nanoparticles for magnetic resonance imaging and enhanced cancer radiation therapy | |
| Li et al. | Pulmonary delivery of theranostic nanoclusters for lung cancer ferroptosis with enhanced chemodynamic/radiation synergistic therapy | |
| Rosa et al. | Biological mechanisms of gold nanoparticle radiosensitization | |
| Štefančíková et al. | Effect of gadolinium-based nanoparticles on nuclear DNA damage and repair in glioblastoma tumor cells | |
| Cui et al. | Hypoxia and cellular localization influence the radiosensitizing effect of gold nanoparticles (AuNPs) in breast cancer cells | |
| Shen et al. | Bottom‐up preparation of uniform ultrathin rhenium disulfide nanosheets for image‐guided photothermal radiotherapy | |
| Dou et al. | Pb@ Au core–satellite multifunctional nanotheranostics for magnetic resonance and computed tomography imaging in vivo and synergetic photothermal and radiosensitive therapy | |
| Xing et al. | Computed tomography imaging-guided radiotherapy by targeting upconversion nanocubes with significant imaging and radiosensitization enhancements | |
| Retif et al. | Nanoparticles for radiation therapy enhancement: the key parameters | |
| Detappe et al. | AGuIX nanoparticles as a promising platform for image-guided radiation therapy | |
| Fan et al. | Rattle-structured multifunctional nanotheranostics for synergetic chemo-/radiotherapy and simultaneous magnetic/luminescent dual-mode imaging | |
| Curcio et al. | Massive intracellular remodeling of CuS nanomaterials produces nontoxic bioengineered structures with preserved photothermal potential | |
| Yang et al. | Tumor angiogenesis targeted radiosensitization therapy using gold nanoprobes guided by MRI/SPECT imaging | |
| Bogdanov Jr et al. | Gold nanoparticles stabilized with MPEG-grafted poly (l-lysine): in vitro and in vivo evaluation of a potential theranostic agent | |
| Dufort et al. | The high radiosensitizing efficiency of a trace of gadolinium-based nanoparticles in tumors | |
| Ferrauto et al. | LipoCEST and cellCEST imaging agents: opportunities and challenges | |
| Detappe et al. | Key clinical beam parameters for nanoparticle-mediated radiation dose amplification | |
| Wang et al. | Self-reporting and splitting nanopomegranates potentiate deep tissue cancer radiotherapy via elevated diffusion and transcytosis |